$304 Million is the total value of Finepoint Capital LP's 57 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 18.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $25,351,000 | +79.1% | 1,028,875 | +76.1% | 8.34% | +70.3% |
| ALGOMA STL GROUP INC | $23,936,000 | -28.3% | 3,716,732 | 0.0% | 7.87% | -31.8% | ||
| PRTA | Sell | PROTHENA CORP PLC | $18,516,000 | +49.1% | 305,400 | -33.2% | 6.09% | +41.8% |
| CYTK | Sell | CYTOKINETICS INC | $18,449,000 | +11.9% | 380,793 | -9.2% | 6.07% | +6.5% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $18,176,000 | +82.4% | 1,111,030 | +57.1% | 5.98% | +73.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $18,174,000 | +26.2% | 266,090 | -16.4% | 5.98% | +20.1% |
| ARVN | New | ARVINAS INC | $17,752,000 | – | 399,000 | +100.0% | 5.84% | – |
| ISEE | IVERIC BIO INC | $17,718,000 | +86.5% | 987,600 | 0.0% | 5.83% | +77.4% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $17,627,000 | -18.4% | 1,688,400 | -16.0% | 5.80% | -22.4% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $16,915,000 | +24.8% | 646,586 | +20.9% | 5.56% | +18.7% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $16,812,000 | +9.4% | 429,313 | -9.7% | 5.53% | +4.1% |
| GLPG | Buy | GALAPAGOS NVspon adr | $16,190,000 | +11.8% | 379,702 | +46.4% | 5.32% | +6.4% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $15,194,000 | +43.3% | 1,586,043 | +65.2% | 5.00% | +36.3% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $15,173,000 | – | 536,901 | +100.0% | 4.99% | – |
| New | DISH NETWORK CORPORATIONnote 12/1 | $13,220,000 | – | 20,000,000 | +100.0% | 4.35% | – | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $12,742,000 | -14.1% | 123,400 | -22.6% | 4.19% | -18.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $10,157,000 | -49.2% | 28,770 | -45.5% | 3.34% | -51.7% |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $8,790,000 | – | 308,092 | +100.0% | 2.89% | – |
| GLOBAL BUSINESS TRAVEL GROUP*w exp 99/99/9999 | $1,433,000 | +49.4% | 913,000 | 0.0% | 0.47% | +41.9% | ||
| BTWNW | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $116,000 | -43.7% | 895,000 | 0.0% | 0.04% | -46.5% | |
| ZIMMER ENERGY TRANSITION ACQUISITION CORP*w exp 06/16/202 | $111,000 | -3.5% | 358,270 | 0.0% | 0.04% | -7.5% | ||
| CONYERS PARK III ACQUISITION CORP*w exp 08/12/202 | $104,000 | -37.3% | 571,666 | 0.0% | 0.03% | -40.4% | ||
| STARRY GROUP HOLDINGS INC*w exp 99/99/999 | $87,000 | -68.5% | 669,000 | 0.0% | 0.03% | -69.5% | ||
| CONCORD ACQUISITION CORP II*w exp 99/99/999 | $86,000 | -4.4% | 408,333 | 0.0% | 0.03% | -9.7% | ||
| CCVIWS | CHURCHILL CAPITAL CORP VI*w exp 02/17/202 | $76,000 | -58.7% | 540,000 | 0.0% | 0.02% | -60.9% | |
| GTPBW | GORES TECHNOLOGY PARTNERS II INC*w exp 03/16/202 | $72,000 | -63.6% | 450,691 | 0.0% | 0.02% | -64.7% | |
| CVIIWS | CHURCHILL CAPITAL CORP VII*w exp 02/29/202 | $74,000 | -61.3% | 548,000 | 0.0% | 0.02% | -63.6% | |
| SUMMIT HEALTHCARE ACQUISITION CORP*w exp 06/03/202 | $74,000 | +64.4% | 489,999 | 0.0% | 0.02% | +50.0% | ||
| KAHCWS | KKR ACQUISITION HOLDINGS I CORP*w exp 99/99/999 | $71,000 | -66.5% | 588,547 | 0.0% | 0.02% | -68.5% | |
| JAWS HURRICANE ACQUISITION CORP*w exp 03/26/202 | $65,000 | -53.2% | 387,249 | 0.0% | 0.02% | -56.2% | ||
| AACWS | ARES ACQUISITION CORP*w exp 99/99/999 | $58,000 | -50.0% | 504,706 | 0.0% | 0.02% | -52.5% | |
| AFTERNEXT HEALTHTECH ACQUISITION CORP*w exp 99/99/999 | $59,000 | -15.7% | 366,666 | 0.0% | 0.02% | -20.8% | ||
| FVIVWS | FORTRESS VALUE ACQUISITION COR*w exp 03/18/202 | $54,000 | -5.3% | 306,513 | 0.0% | 0.02% | -10.0% | |
| CCVWS | CHURCHILL CAPITAL CORP V*w exp 10/29/202 | $52,000 | -74.3% | 612,000 | 0.0% | 0.02% | -75.7% | |
| BERENSON ACQUISITION CORP I*w exp 08/01/202 | $44,000 | -63.6% | 862,499 | 0.0% | 0.01% | -66.7% | ||
| SKYDECK ACQUISITION CORP*w exp 05/13/202 | $42,000 | -22.2% | 361,756 | 0.0% | 0.01% | -26.3% | ||
| COMPASS DIGITAL ACQUISITION CORP*w exp 09/29/202 | $41,000 | -64.3% | 459,906 | 0.0% | 0.01% | -67.5% | ||
| BILANDER ACQUISITION CORP*w exp 05/19/202 | $36,000 | -34.5% | 183,749 | 0.0% | 0.01% | -36.8% | ||
| CATALYST PARTNERS ACQUISITION*w exp 05/12/202 | $37,000 | -47.9% | 336,666 | 0.0% | 0.01% | -52.0% | ||
| FIRST LIGHT ACQUISITION GROUP INC*w exp 03/14/202 | $37,000 | -37.3% | 655,200 | 0.0% | 0.01% | -40.0% | ||
| GTPAW | GORES TECHNOLOGY PARTNERS INC*w exp 03/16/202 | $38,000 | -63.8% | 201,000 | 0.0% | 0.01% | -66.7% | |
| ROSSWS | ROSS ACQUISITION CORP II*w exp 02/01/202 | $34,000 | -50.0% | 439,666 | 0.0% | 0.01% | -54.2% | |
| FCAXWS | FORTRESS CAPITAL ACQUISITION C*w exp 99/99/999 | $31,000 | -56.3% | 392,000 | 0.0% | 0.01% | -60.0% | |
| CORSAIR PARTNERING CORP*w exp 07/06/202 | $28,000 | -58.2% | 334,666 | 0.0% | 0.01% | -60.9% | ||
| FVTWS | FORTRESS VALUE ACQUISITION COR*w exp 12/31/202 | $23,000 | -43.9% | 225,000 | 0.0% | 0.01% | -42.9% | |
| SWIFTMERGE ACQUISITION CORP*w exp 12/13/202 | $25,000 | -53.7% | 490,000 | 0.0% | 0.01% | -57.9% | ||
| CRHCWS | COHN ROBBINS HOLDINGS CORP*w exp 08/28/202 | $21,000 | -94.6% | 904,000 | 0.0% | 0.01% | -94.8% | |
| SPGSWS | SIMON PROPERTY GROUP ACQUISITION HOLDINGS INC*w exp 02/04/202 | $22,000 | -64.5% | 335,200 | 0.0% | 0.01% | -66.7% | |
| HOME PLATE ACQUISITION CORP*w exp 09/30/202 | $17,000 | -86.3% | 690,000 | 0.0% | 0.01% | -86.0% | ||
| REVHW | REVOLUTION HEALTHCARE ACQUISIT*w exp 12/31/202 | $17,000 | -84.3% | 432,639 | 0.0% | 0.01% | -83.8% | |
| HAACW | HEALTH ASSURANCE ACQUISITION C*w exp 11/12/202 | $19,000 | -78.2% | 643,000 | 0.0% | 0.01% | -80.0% | |
| MARBLEGATE ACQUISITION CORP*w exp 08/31/202 | $16,000 | -78.4% | 735,000 | 0.0% | 0.01% | -80.8% | ||
| LVRAW | LEVERE HOLDINGS CORP*w exp 03/09/202 | $14,000 | -36.4% | 274,999 | 0.0% | 0.01% | -37.5% | |
| SNRHW | SENIOR CONNECT ACQUISITION COR*w exp 12/31/202 | $10,000 | -85.9% | 1,014,000 | 0.0% | 0.00% | -88.0% | |
| WPCBWS | WARBURG PINCUS CAPITAL CORP I-B*w exp 99/99/999 | $8,000 | -76.5% | 125,000 | 0.0% | 0.00% | -75.0% | |
| TMACWS | MUSIC ACQUISITION CORP/THE*w exp 02/05/202 | $3,000 | -57.1% | 75,250 | 0.0% | 0.00% | -50.0% | |
| WPCAWS | WARBURG PINCUS CAPITAL CORP I-A*w exp 99/99/999 | $1,000 | -80.0% | 14,999 | 0.0% | 0.00% | -100.0% | |
| EQDWS | Exit | Equity Distribution Acquisitio*w exp 09/09/202 | $0 | – | -669,000 | -100.0% | -0.02% | – |
| IPOFWS | Exit | Social Capital Hedosophia Holdings Corp VI*w exp 09/26/202 | $0 | – | -671,000 | -100.0% | -0.11% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -735,126 | -100.0% | -2.01% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -203,200 | -100.0% | -4.19% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -210,200 | -100.0% | -4.88% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -474,000 | -100.0% | -5.24% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -211,000 | -100.0% | -5.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| YPF SOCIEDAD ANONIMA | 17 | Q4 2018 | 32.7% |
| IRSA INVERSIONES Y REP S A | 15 | Q2 2018 | 10.1% |
| CHENIERE ENERGY INC | 14 | Q1 2018 | 29.9% |
| ALLY FINL INC | 13 | Q4 2017 | 42.0% |
| CRESUD S A C I F Y A | 13 | Q4 2017 | 4.0% |
| BRIDGETOWN HOLDINGS LTD | 9 | Q3 2023 | 0.2% |
| ARES ACQUISITION CORP | 9 | Q3 2023 | 0.2% |
| CHURCHILL CAPITAL CORP V | 9 | Q3 2023 | 0.2% |
| CHURCHILL CAPITAL CORP VII | 9 | Q3 2023 | 0.1% |
| CHURCHILL CAPITAL CORP VI | 9 | Q3 2023 | 0.1% |
View Finepoint Capital LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View Finepoint Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.